Dr. Harry P. Selker is Dean of Tufts Clinical and Translational Science Institute (CTSI) and Executive Director of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. As Dean, he provides leadership for programs and infrastructure that support clinical and translational research at the Tufts University schools and affiliated hospitals, and other academic, community-based, and industry CTSI partners. He practices medicine at Tufts Medical Center. Dr. Selker‘s research focuses on the development of treatment strategies, decision aids, and systems aimed at improving medical care. He is known for his studies of the factors influencing emergency cardiac care and for development of "clinical predictive instruments," mathematical models that are used as decision aids. They provide emergency physicians and paramedics with predictions for their patients’ likely cardiac diagnoses and outcomes for real-time use in clinical care. This has included conduct of multiple large national clinical effectiveness trials that have demonstrated better treatment and clinical outcomes for patients with acute coronary syndromes. Additionally, Dr. Selker has done research to advance clinical study design, execution, issues around informed consent, data analysis, mathematical predictive modeling of medical outcomes, and comparative effectiveness research. Dr. Selker has contributed to health services and health policy research, with a focus on translational research that impacts public health. He has provided advice about healthcare delivery and medical research to policymakers, including the House and Senate authors of the Affordable Care Act. Dr. Selker has served as President of the Society of General Internal Medicine, the Society for Clinical and Translational Science, the Association for Clinical Research Training, and the Association for Clinical and Translational Science, and is currently Chair of the Clinical Research Forum.